Form D · Biotechnology

SalivIQ Diagnostics Inc.

Harrisonburg, VA · CIK 0002138504

Offering snapshot reported Sep 23, 2026 · SEC filing

Reported sold
$1.91M
Offering amount: $3.17M
Investors reported
50
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
May 26, 2026
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$956K$1.91MJun 10, 2026: $1,205,000.00Jun 10, 2026Sep 23, 2026: $1,911,999.00Sep 23, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,205,000 → $1,911,999
  • Reported investors36 → 50

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 23, 2026Amendment$1,911,999$706,999vs Jun 10, 202650SEC filing
Jun 10, 2026Initial$1,205,000No comparison36SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-586808

Source: Form D, filed Sep 23, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gregory Bell Director
John Cheneval Director
Julia Ann Halterman Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1200 Park Road
Harrisonburg, VA, 22802
Phone: 540-205-8479